Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

A Multidimensional Intervention to Improve Ethical Decision-Making Competence Among Nursing Student Interns

5 de noviembre de 2026 actualizado por: Qiuyu Zhang, Yangzhou University

The goal of this randomized controlled trial is to evaluate the effectiveness of a 5-week multidimensional intervention in improving ethical decision-making competence among nursing student interns. The intervention is designed to address multiple factors influencing ethical decision-making during clinical training. The study will also examine whether the effects of the intervention are maintained at 1-month and 3-month follow-ups after the intervention ends.

The main questions it aims to answer are:

  1. Does the 5-week multidimensional intervention improve ethical decision-making competence among nursing student interns compared with usual clinical internship training?
  2. Are the effects of the intervention maintained at 1-month and 3-month follow-ups after the intervention ends?

Researchers will compare nursing student interns who receive the 5-week multidimensional intervention with those who receive usual clinical internship training to evaluate the intervention's effectiveness.

Participants will:

  1. Complete questionnaires assessing all study outcome measures at baseline, at the end of the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention ends.
  2. Participate in the educational activities provided to their assigned study group.
  3. Complete follow-up assessments as scheduled.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Estimado)

108

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  1. Undergraduate nursing student interns undertaking clinical internships at tertiary Grade A hospitals.
  2. First-time hospital interns with no more than 3 months of internship experience.
  3. Good communication and language expression skills.
  4. Willingness to participate in the study and provide informed consent.

Exclusion Criteria:

  1. Individuals with a history of mental illness or communication difficulties.
  2. Nursing student interns who discontinue their hospital internship or take a leave of absence from their studies during the study period.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Multidimensional Intervention Group

Participants assigned to this group will receive a 5-week multidimensional intervention designed to improve ethical decision-making competence among nursing student interns during clinical learning. The intervention will address factors relevant to ethical decision-making through structured educational activities. Participants will complete outcome assessments at baseline, at the end of the intervention, and at 1-month and 3-month follow-ups after the intervention ends.

A 5-week multidimensional educational intervention to improve ethical decision-making competence among nursing student interns. Sessions will be delivered once weekly, lasting 1.5-2 hours each. The intervention includes five modules: (1) ethical issue recognition; (2) ethical emotion regulation; (3) ethical reasoning and decision-making; (4) ethical expression and action; and (5) clinical teaching rounds. The intervention aims to strengthen participants' ethical awareness, emotional regulation, decision-making, and ability to address ethical challenges during clinical learning.

Participants in the usual clinical internship training group will receive routine clinical learning and teaching according to the hospital's established training program. Regular activities include clinical skills training, observation and participation in nursing care under the supervision of clinical instructors, case discussions. When encountering ethical issues during clinical learning, participants will generally seek advice from their clinical instructors or supervising nurses. No additional study-specific intervention will be provided.

Comparador activo: Usual Clinical Internship Training Group

Participants assigned to this group will receive usual clinical internship training according to the hospital's standard training arrangements. They will not receive the study-specific 5-week multidimensional intervention during the intervention period. Participants will complete outcome assessments at baseline, at the end of the 5-week intervention period, and at 1-month and 3-month follow-ups after the intervention period ends.

Participants in the usual clinical internship training group will receive routine clinical learning and teaching according to the hospital's established training program. Regular activities include clinical skills training, observation and participation in nursing care under the supervision of clinical instructors, case discussions. When encountering ethical issues during clinical learning, participants will generally seek advice from their clinical instructors or supervising nurses. No additional study-specific intervention will be provided.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Ethical Decision-Making Competence Scale
Periodo de tiempo: At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.

The scale consists of 18 items across four dimensions and assesses nursing students' creativity, confidence, awareness, and neutrality when facing ethical decision-making dilemmas involving patients or their families. It is based on Rest's Four-Component Model of Ethical Decision-Making, comprising ethical judgment, ethical sensitivity, ethical motivation, and ethical action. Each item is rated on a 5-point Likert scale ranging from 0 (strongly disagree) to 4 (strongly agree). The total score ranges from 0 to 72, with higher scores indicating a higher level of ethical decision-making competence.

At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Clance Impostor Phenomenon Scale
Periodo de tiempo: At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.

This scale measures nurses' levels of imposter phenomenon and their attributions. It consists of 18 items across three dimensions: passive concealment (4 items), external attribution (6 items), and self-doubt (8 items). Each item is rated on a 5-point Likert scale ranging from 1 ("completely inconsistent") to 5 ("completely consistent"). The total score ranges from 18 to 90, with higher scores indicating a more severe imposter phenomenon.

At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.
Rushton Moral Resilience Scale
Periodo de tiempo: At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.

The scale consists of 17 items across three dimensions: coping with nursing ethical dilemmas and relational integrity (10 items), personal integrity (2 items), and ethical efficacy in nursing (5 items). Each item is rated on a 4-point Likert scale ranging from 1 ("strongly disagree") to 4 ("strongly agree"). The total score ranges from 17 to 68, with higher scores indicating greater ethical resilience.

At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.
Moral Sensitivity Questionnaire for Nursing Students
Periodo de tiempo: At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.

This scale measures nursing students' moral sensitivity and consists of 11 items across three dimensions: moral strength (4 items), moral burden (5 items), and moral responsibility (2 items). Each item is rated on a 6-point Likert scale ranging from 1 ("strongly disagree") to 6 ("strongly agree"). The total score ranges from 11 to 66, with higher scores indicating greater moral sensitivity.

At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.
Professional Quality Of Life Scale
Periodo de tiempo: At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.

The scale consists of three dimensions: compassion satisfaction (CS), burnout (BO), and secondary traumatic stress (STS). CS represents a positive aspect, whereas BO and STS represent negative aspects. Items are rated on a 5-point Likert scale ranging from 1 ("never") to 5 ("always"). The cutoff scores for CS, BO, and STS are 27, and >17, respectively. Compassion fatigue severity is classified as mild when one dimension exceeds its cutoff, moderate when two dimensions exceed their cutoffs, and severe when all three dimensions exceed their cutoffs.

At baseline, immediately after the 5-week intervention, and at 1-month and 3-month follow-ups after the intervention.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de noviembre de 2026

Finalización primaria (Estimado)

1 de marzo de 2027

Finalización del estudio (Estimado)

1 de abril de 2027

Fechas de registro del estudio

Enviado por primera vez

19 de octubre de 2026

Primero enviado que cumplió con los criterios de control de calidad

19 de octubre de 2026

Publicado por primera vez (Actual)

26 de octubre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

10 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

5 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • YXYLL-2025-140

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir